Biogen Book Value Per Share from 2010 to 2025

BIIB Stock

USD 142.43 3.27 2.35%

Biogen's Book Value Per Share is increasing over the years with slightly volatile fluctuation. Overall, Book Value Per Share is expected to go to 120.47 this year. Book Value Per Share is the ratio of equity available to common shareholders divided by the number of outstanding shares. This measure represents the value per share of Biogen Inc according to its financial statements. View All Fundamentals

Book Value Per Share

First Reported

2010-12-31

Previous Quarter

114.72889499

Current Value

120.47

Quarterly Volatility

33.21424337

Credit Downgrade

Yuan Drop

Covid

Check Biogen financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Biogen's main balance sheet or income statement drivers, such as Depreciation And Amortization of 597.5 M, Interest Expense of 262.8 M or Selling General Administrative of 2.5 B, as well as many indicators such as Price To Sales Ratio of 2.19, Dividend Yield of 0.0022 or PTB Ratio of 1.27. Biogen financial statements analysis is a perfect complement when working with Biogen Valuation or Volatility modules.

Check out the analysis of Biogen Correlation against competitors.

Latest Biogen's Book Value Per Share Growth Pattern

Below is the plot of the Book Value Per Share of Biogen Inc over the last few years. It is the ratio of equity available to common shareholders divided by the number of outstanding shares. This measure represents the value per share of a company according to its financial statements. Biogen's Book Value Per Share historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Biogen's overall financial position and show how it may be relating to other accounts over time.

View

Last Reported 114.65 X

10 Years Trend

Slightly volatile

Compare to Others All Fundamentals

Book Value Per Share

Timeline

Biogen Book Value Per Share Regression Statistics

	Arithmetic Mean	62.37
	Geometric Mean	41.73
	Coefficient Of Variation	53.25
	Mean Deviation	25.68
	Median	63.60
	Standard Deviation	33.21
	Sample Variance	1,103
	Range	120
	R-Value	0.98
	Mean Square Error	55.62
	R-Squared	0.95
	Slope	6.81
	Total Sum of Squares	16,548

Biogen Book Value Per Share History

	2025	120.47
	2024	114.73
	2023	102.28
	2022	92.14
	2021	73.51
	2020	66.41
	2019	71.29

Other Fundumenentals of Biogen Inc

Tangible Book Value Per Share

Biogen Book Value Per Share component correlations

	Total Assets	Total Stockholder Equity	Net Debt	Retained Earnings	Net Receivables	Total Liab	Total Current Assets	Intangible Assets	Accounts Payable	Short Term Investments	Common Stock	Short Term Debt	Long Term Debt	Property Plant Equipment	Current Deferred Revenue	Treasury Stock	Good Will	Net Tangible Assets	Long Term Debt Total	Capital Surpluse	Deferred Long Term Liab	Long Term Investments	Short Long Term Debt	Net Invested Capital	Net Working Capital	Capital Stock
Total Assets		0.94	0.82	0.98	0.77	0.95	0.93	0.62	0.89	0.16	-0.79	0.56	0.78	0.88	-0.33	-0.91	0.85	0.33	0.82	-0.95	0.41	-0.18	0.64	0.04	-0.39	-0.39
Total Stockholder Equity	0.94		0.62	0.95	0.61	0.78	0.84	0.77	0.78	-0.02	-0.81	0.58	0.56	0.78	-0.15	-0.83	0.71	0.52	0.63	-0.8	0.26	-0.26	0.6	0.09	-0.39	-0.53
Net Debt	0.82	0.62		0.79	0.72	0.91	0.75	0.41	0.72	0.26	-0.55	0.32	0.93	0.76	-0.33	-0.74	0.81	0.0	0.93	-0.92	0.28	-0.1	0.46	0.12	-0.4	-0.17
Retained Earnings	0.98	0.95	0.79		0.71	0.91	0.92	0.67	0.83	0.11	-0.72	0.56	0.75	0.83	-0.25	-0.89	0.83	0.42	0.81	-0.93	0.33	-0.17	0.62	0.03	-0.37	-0.44
Net Receivables	0.77	0.61	0.72	0.71		0.83	0.8	0.13	0.81	0.38	-0.64	0.13	0.84	0.9	-0.42	-0.89	0.86	0.17	0.76	-0.78	0.4	0.04	0.28	-0.22	-0.07	0.24
Total Liab	0.95	0.78	0.91	0.91	0.83		0.91	0.42	0.89	0.31	-0.69	0.48	0.89	0.88	-0.46	-0.88	0.9	0.12	0.9	-0.98	0.5	-0.08	0.61	-0.01	-0.35	-0.21
Total Current Assets	0.93	0.84	0.75	0.92	0.8	0.91		0.38	0.86	0.41	-0.77	0.39	0.82	0.85	-0.33	-0.91	0.8	0.33	0.82	-0.94	0.33	0.14	0.45	-0.24	-0.09	-0.2
Intangible Assets	0.62	0.77	0.41	0.67	0.13	0.42	0.38		0.36	-0.49	-0.48	0.52	0.2	0.36	0.21	-0.43	0.36	0.47	0.34	-0.45	-0.03	-0.56	0.5	0.49	-0.65	-0.75
Accounts Payable	0.89	0.78	0.72	0.83	0.81	0.89	0.86	0.36		0.16	-0.72	0.54	0.7	0.87	-0.55	-0.84	0.85	0.17	0.71	-0.84	0.5	-0.2	0.62	-0.14	-0.3	-0.23
Short Term Investments	0.16	-0.02	0.26	0.11	0.38	0.31	0.41	-0.49	0.16		-0.3	-0.19	0.48	0.29	-0.28	-0.32	0.14	-0.28	0.35	-0.36	0.19	0.8	-0.17	-0.3	0.43	0.5
Common Stock	-0.79	-0.81	-0.55	-0.72	-0.64	-0.69	-0.77	-0.48	-0.72	-0.3		-0.32	-0.56	-0.77	0.15	0.79	-0.51	-0.22	-0.53	0.73	-0.19	-0.01	-0.35	0.0	0.2	0.21
Short Term Debt	0.56	0.58	0.32	0.56	0.13	0.48	0.39	0.52	0.54	-0.19	-0.32		0.12	0.43	-0.54	-0.33	0.47	0.26	0.28	-0.43	0.59	-0.5	0.93	0.33	-0.61	-0.65
Long Term Debt	0.78	0.56	0.93	0.75	0.84	0.89	0.82	0.2	0.7	0.48	-0.56	0.12		0.8	-0.31	-0.79	0.82	0.06	0.96	-0.91	0.23	0.16	0.26	-0.13	-0.12	0.09
Property Plant Equipment	0.88	0.78	0.76	0.83	0.9	0.88	0.85	0.36	0.87	0.29	-0.77	0.43	0.8		-0.45	-0.88	0.92	0.32	0.81	-0.86	0.41	-0.1	0.52	-0.03	-0.31	-0.04
Current Deferred Revenue	-0.33	-0.15	-0.33	-0.25	-0.42	-0.46	-0.33	0.21	-0.55	-0.28	0.15	-0.54	-0.31	-0.45		0.29	-0.51	0.14	-0.28	0.35	-0.76	0.16	-0.56	0.05	0.14	-0.12
Treasury Stock	-0.91	-0.83	-0.74	-0.89	-0.89	-0.88	-0.91	-0.43	-0.84	-0.32	0.79	-0.33	-0.79	-0.88	0.29		-0.8	-0.25	-0.76	0.88	-0.34	-0.02	-0.42	0.08	0.19	0.09
Good Will	0.85	0.71	0.81	0.83	0.86	0.9	0.8	0.36	0.85	0.14	-0.51	0.47	0.82	0.92	-0.51	-0.8		0.35	0.86	-0.85	0.47	-0.22	0.58	-0.04	-0.36	-0.09
Net Tangible Assets	0.33	0.52	0.0	0.42	0.17	0.12	0.33	0.47	0.17	-0.28	-0.22	0.26	0.06	0.32	0.14	-0.25	0.35		0.16	-0.19	-0.12	-0.13	0.11	-0.04	-0.04	-0.24
Long Term Debt Total	0.82	0.63	0.93	0.81	0.76	0.9	0.82	0.34	0.71	0.35	-0.53	0.28	0.96	0.81	-0.28	-0.76	0.86	0.16		-0.93	0.21	0.04	0.42	-0.04	-0.28	-0.11
Capital Surpluse	-0.95	-0.8	-0.92	-0.93	-0.78	-0.98	-0.94	-0.45	-0.84	-0.36	0.73	-0.43	-0.91	-0.86	0.35	0.88	-0.85	-0.19	-0.93		-0.36	-0.03	-0.52	0.04	0.28	0.24
Deferred Long Term Liab	0.41	0.26	0.28	0.33	0.4	0.5	0.33	-0.03	0.5	0.19	-0.19	0.59	0.23	0.41	-0.76	-0.34	0.47	-0.12	0.21	-0.36		-0.19	0.66	0.09	-0.27	0.01
Long Term Investments	-0.18	-0.26	-0.1	-0.17	0.04	-0.08	0.14	-0.56	-0.2	0.8	-0.01	-0.5	0.16	-0.1	0.16	-0.02	-0.22	-0.13	0.04	-0.03	-0.19		-0.56	-0.43	0.67	0.51
Short Long Term Debt	0.64	0.6	0.46	0.62	0.28	0.61	0.45	0.5	0.62	-0.17	-0.35	0.93	0.26	0.52	-0.56	-0.42	0.58	0.11	0.42	-0.52	0.66	-0.56		0.3	-0.67	-0.63
Net Invested Capital	0.04	0.09	0.12	0.03	-0.22	-0.01	-0.24	0.49	-0.14	-0.3	0.0	0.33	-0.13	-0.03	0.05	0.08	-0.04	-0.04	-0.04	0.04	0.09	-0.43	0.3		-0.81	-0.27
Net Working Capital	-0.39	-0.39	-0.4	-0.37	-0.07	-0.35	-0.09	-0.65	-0.3	0.43	0.2	-0.61	-0.12	-0.31	0.14	0.19	-0.36	-0.04	-0.28	0.28	-0.27	0.67	-0.67	-0.81		0.51
Capital Stock	-0.39	-0.53	-0.17	-0.44	0.24	-0.21	-0.2	-0.75	-0.23	0.5	0.21	-0.65	0.09	-0.04	-0.12	0.09	-0.09	-0.24	-0.11	0.24	0.01	0.51	-0.63	-0.27	0.51

Click cells to compare fundamentals

About Biogen Financial Statements

Biogen stakeholders use historical fundamental indicators, such as Biogen's Book Value Per Share, to determine how well the company is positioned to perform in the future. Although Biogen investors may analyze each financial statement separately, they are all interrelated. For example, changes in Biogen's assets and liabilities are reflected in the revenues and expenses on Biogen's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Biogen Inc. Please read more on our technical analysis and fundamental analysis pages.

	Last Reported	Projected for Next Year
Book Value Per Share	114.73	120.47
Tangible Book Value Per Share	3.75	6.62

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

ZLAB	Zai Lab
ASLE	AerSale Corp
ATS	AT S Austria

When determining whether Biogen Inc offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Biogen's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Biogen Inc Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Biogen Inc Stock:

How To Invest In Biogen

Details

Is Biogen Stock a good investment?

Details

What is Biogen's Net Worth?

Details

Largest Biotechnology Companies

View

Largest Pharmaceuticals, Biotechnology & Life Sciences Companies

View

Check out the analysis of Biogen Correlation against competitors.

You can also try the Alpha Finder module to use alpha and beta coefficients to find investment opportunities after accounting for the risk.

Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Biogen. If investors know Biogen will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Biogen listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Quarterly Earnings Growth

0.063

Earnings Share

11.18

Revenue Per Share

66.455

Quarterly Revenue Growth

0.029

Return On Assets

0.0529

The market value of Biogen Inc is measured differently than its book value, which is the value of Biogen that is recorded on the company's balance sheet. Investors also form their own opinion of Biogen's value that differs from its market value or its book value, called intrinsic value, which is Biogen's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Biogen's market value can be influenced by many factors that don't directly affect Biogen's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Biogen's value and its price as these two are different measures arrived at by different means. Investors typically determine if Biogen is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Biogen's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Biogen Book Value Per Share from 2010 to 2025

Latest Biogen's Book Value Per Share Growth Pattern

Biogen Book Value Per Share Regression Statistics

Biogen Book Value Per Share History

Other Fundumenentals of Biogen Inc

Biogen Book Value Per Share component correlations

About Biogen Financial Statements

Also Currently Popular

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY